Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-25 @ 9:43 PM
Study NCT ID:
NCT03488251
Status:
TERMINATED
Last Update Posted:
2022-08-16
First Post:
2018-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Sponsor:
Molecular Templates, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MT-3724_NHL_002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None